Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit

Get the dosing wrong, and you waste expensive peptides
It is reflected in mortality data showing that cardiovascular disease is a leading cause of death in SLE, particularly in patients who survive the first five years after diagnosis
Some people though, might not need or want the full prescribed amount
What to avoid during peak nausea: Anything fried, fatty meat, dairy (except plain yogurt), spicy foods, strong smells, hot foods (cold or room temperature better), coffee (for most, some find it helps), alcohol (amplifies nausea dramatically)
Dabo Glutathione Whitening Solution Ampoule is a concentrated serum designed to brighten and even out skin tone